Moreover, elevated brain glutamine concenThe aim of this study was to investigate the possible trations can induce cell swelling, resulting in brain edema, 8, 9 role of N-methyl-D-aspartate (NMDA)-receptor overaca terminal event in patients with fulminant hepatic failure.
10 tivity in two different experimental rat models of enElevation of cerebral extracellular and cerebrospinal fluid cephalopathy: subacute encephalopathy caused by se-(CSF) concentrations of glutamate and aspartate has also vere hyperammonemia in portacaval-shunted rats been observed in experimental 9, [11] [12] [13] [14] and clinical 15-17 HE, and (AI-PCS rats) and acute hepatic encephalopathy caused it has been hypothesized that these two excitatory neuroby complete liver ischemia (LIS rats). The effect of the transmitters are implicated in the pathogenesis of HE. Glutanoncompetitive NMDA-receptor antagonist memantine mate and aspartate can bind to different types of excitatory (intraperitoneal [i.p.] 10-20 mg/kg bw or intravenous receptors (metabotropic and ionotropic), of which the N-[i.v.] 5 mg/kg bw) was studied on the severity of encephamethyl-D-aspartate (NMDA) receptor has been best characlopathy by assessment of clinical grading and electroenterized. 18 A fast increase in extracellular glutamate and cephalogram (EEG) spectral analysis, on plasma ammoaspartate concentrations observed in (sub)acute liver failure nia concentrations, amino acid concentrations in can result in an overstimulation of the NMDA receptor. This cerebrospinal fluid (CSF), intracranial pressure (ICP), NMDA-receptor overactivity leads to an increased influx of and brain water content. Both rat models developed endifferent ions (Na creased CSF glutamate and aspartate concentrations This study was designed to investigate the role of NMDAand increased ICP and brain water content. Memantine receptor activity in hyperammonemia-induced encephalopaadministration in AI-PCS and LIS rats resulted in a sigthy and liver ischemia-induced HE, two experimental rat nificant improvement in clinical grading and less slowmodels that both are associated with intracranial hypertening of EEG activity (P õ .05), and smaller increases in sion. Therefore, the noncompetitive NMDA-receptor antago-CSF glutamate (P õ .05) concentrations. Moreover, ICP nist memantine 21-24 was administered to portacaval-shunted and brain water content were significantly lower in (PCS) rats with an ammonium-acetate infusion and to rats memantine-treated AI-PCS rats than in untreated AIwith complete liver ischemia. The severity of encephalopathy PCS rats (P õ .05). Memantine had no significant effect was quantified by clinical grading and electroencephalogram on ICP and brain water content in LIS rats, and on am-(EEG) spectral analysis. Plasma concentrations of ammonia monia concentrations in both models. These results indiand memantine, and CSF concentrations of amino acids, were cate that NMDA-receptor activation might be involved assessed. Intracranial pressure was measured with a presin the pathogenesis of hyperammonemia-induced ensure transducer connected to a cisterna magna cannula, and, cephalopathy and of acute hepatic encephalopathy in addition, brain water content was assessed at the end of caused by LIS. (HEPATOLOGY 1997;25:820-827.) the experiment. Animal welfare was in accordance with the guidelines of the Univerconcentrations, and it has been suggested that brain glutasity of Amsterdam. mine more than brain ammonia is implicated in the pathoTwo different experimental groups were studied: 1) PCS rats with an ammonium-acetate infusion (AI-PCS rats), and 2) rats with liver ischemia (LIS rats).
AI-PCS Rats. One week before the ammonium-acetate infusion, a memantine. In the case of intraperitoneal (i.p.) injection of meman- In all series of experiments, blood samples were taken from the carotid artery to measure blood ammonia concentration (0.05 mL every hour) or plasma memantine concentration (1.0 mL at the end LIS Rats. A ligation of the hepatic artery was performed under of the experiment). Additionally, in the LIS rats, blood glucose was ether anesthesia 1 week after PCS surgery. After devascularization, measured every hour (Haemo-Glukotest, Boehringer Mannheim, the carotid artery was cannulated and an i.p. catheter was placed for Mannheim, Germany). Mean arterial blood pressure was measured memantine and glucose (5%) administration. In both experimental every 2 hours via the carotid artery that was connected to a pressure groups, body temperature was kept constant between 36ЊC and 37ЊC transducer (Viggo-Spectramed DTX/Plus disposable transducer kit). by a heating lamp, because Traber et al. showed that normothermic Ammonia concentration was measured with the Blood Ammonia devascularized rats developed brain edema, whereas hypothermic Checker II (Kyoto Daiichi Kagaku Co., Ltd., Kyoto, Japan). 29 Amino devascularized rats did not. 26 acid concentrations were measured after deproteinization by highMemantine (1-amino-3,5-dimethyladamantane hydrochloride; pressure liquid chromatography analysis as described by van Eijk Akatinol memantine) was a generous gift from Merz and Co., GmbH et al. 30 Memantine concentration was measured by gas chromatogra-(Frankfurt/Main, Germany), and was dissolved in 0.9% saline in a phy/mass spectroscopy as described by Danysz et al. The results of clinical administrations were combined and used as data from one control grading are analyzed separately for both series of experiments. group for the AI-PCS rats. Control LIS rats received i.p. administra-ANOVA (one-way procedure) was used for differences between the tion of 0.9% saline).
experimental groups in Table 2 and Fig. 4 . When the ANOVA procedure showed statistical significance, the Scheffé procedure was used Experimental Procedures for individual group comparison. Levels of significance were set at P õ .05. Two different series of experiments were performed in AI-PCS rats and LIS rats: RESULTS In the first series of experiments, the development of encephalopathy was determined by clinical grading of encephalopathy and EEG General Aspects. Blood ammonia concentration in AI-PCS spectral analysis (n Å 7 per group, except control LIS rats: n Å rats reached a steady-state concentration of approximately 5). Encephalopathy was graded clinically according to the level of 1,000 mmol/L within 1 hour after the start of the ammoniumconsciousness, using the five grades shown in Table 1. acetate infusion. This steady state was maintained during Five days before a PCS was performed, four golden skull electrodes the rest of the infusion (Fig. 1A) . Memantine administration were implanted, and, on the day of the experiment, EEG spectral (either i.p. or i.v.) did not affect the blood ammonia levels in analysis was performed for four EEG power band regions within the range of 1 to 26.5 Hz.
glucose concentrations remained between 6 and 10 mmol/L moved and frozen in liquid nitrogen. They were stored at 070ЊC until (data not shown).
determination of memantine concentrations.
Severity of Encephalopathy. Clinical grading of encepha-
In the second series of experiments (n Å 7 per group, except control lopathy and EEG spectral analysis showed that the AI-PCS LIS rats: n Å 5), amino acids in CSF were assessed and intracranial rats developed encephalopathy within the 6 hours of ammopressure (ICP) was measured. (In addition, clinical grading of ennium-acetate infusion (Fig. 2) . However, when rats were cephalopathy was also measured in this series of experiments). treated with memantine (either i.p. or i.v.), a significantly A cisterna magna cannula was implanted according to the techsmaller increase in clinical grade was observed ( Fig. 2A ; P nique of Boer et al. 28 1 day before the experiment. After the rat õ .05). Additionally, separate analysis of the subgroups (rats was anesthetized (30 mg/kg nembutal i.p.), a stainless-steel cannula (outside diameter 0.8 mm) was positioned by hand and fixed to the with a cisterna magna canula or skull electrodes) showed skull by a round plate soldered at an angle of 45Њ using dental cement. significant differences in clinical grade (P õ .05). For this Aliquots of 50 mL CSF from the cisterna magna cannula were reason, the data were pooled together in Figs. 2 and 3 . Admintaken for amino acid analysis at the start and end of the experiment.
istration of this NMDA-receptor antagonist further resulted CSF samples were frozen in liquid nitrogen immediately after sam-in a positive effect on EEG activity. After both i.p. and i.v. pling and stored at 080ЊC until required for analysis of amino acids. injection, EEG left index showed a smaller increase, in which
The cisterna magna cannula was also used to measure the ICP at the EEG left index after i.p. administration was significantly the start and end of the experiment, just before CSF samples were lower than untreated rats ( Fig. 2B ; P õ .05). The MDF taken. The cisterna magna cannula was connected with a pressure showed a significantly smaller decrease in both treated transducer (Viggo-Spectramed DTX/Plus disposable transducer kit, Ohmeda, Singapore), which monitored the ICP.
groups compared with controls ( Fig. 2C ; P õ .0001).
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spontaneous'' death (60%) or by killing (40%). Memantine was administered at a dose of 10 to 20 mg/kg body weight i.p. when righting reflex disappeared (clinical grade 3), and, as shown in Fig. 3 , the NMDA-receptor antagonist induced a significant improvement in clinical grading (P õ .05), in EEG left index (P õ .05) and in MDF (P õ .01), during the registration period of 3 hours. After this, the clinical manifestations of the LIS rats deteriorated comparable with that in LIS rats without memantine. However, none of the treated LIS rats died spontaneously when clinical grade 5 was reached.
In addition, EEG spectral analysis was performed during 4 hours in normal rats that received memantine (i.p. 10 mg/ kg body weight). EEG left index did not change after memantine administration: the initial value of 0.73 { 0.01 was simi- 1 hour after the start of the infusion, resulted in a higher plasma memantine concentration measured at the end of the experiment (i.e., 334 { 32 ng/mL) compared with i.v. injection of 5 mg/kg body weight memantine (i.e., 196 { 16 ng/mL). Memantine concentration in brain was 5.74 { 0.63 mg/g brain wet weight (n Å 4 in AI-PCS rats with i.v. injection of memantine).
Amino Acid Concentrations in CSF. CSF concentrations of glutamate and aspartate were elevated in AI-PCS and LIS rats at the end of the experiment (Fig. 4A and 4B ). Memantine administration in both rat models resulted in a smaller increase in CSF glutamate concentrations (P õ .05 in i.p.-treated AI- 2 mm Hg to variable values of 5 to 20 mm Hg (Fig. 5) . How-
AID Hepa 0032
/ 5p1e$$$622 03-13-97 14:48:47 hpta WBS: Hepatology ever, ICP in AI-PCS rats with i.p. administration of memantine remained constant with a maximal value of 5 mm Hg, and was significantly lower than in controls (P õ .01). Although ICP in AI-PCS rats with i.v. administration of memantine was not significantly lower than in controls, only two of the seven rats reached an ICP of 8 and 9 mm Hg. Memantine administration in LIS rats did not result in a lower ICP (Fig. 6) . ICP of LIS rats with and without memantine increased from approximately 3 mm Hg to values of 10 to 25 mm Hg. As shown in Table 2 , brain water content of AI-PCS rats is significantly higher than brain water content in normal rats. 9 Although the difference is small, LIS rats show an even higher brain water content than AI-PCS rats. Memantine administration resulted in a significantly lower brain water content in AI-PCS rats only, compared with untreated rats.
DISCUSSION
The exact pathophysiological mechanism of HE is still a matter of debate, but it is believed to be multifactorial. Previ- analysis was performed by repeated MANOVA. ICP was not significantly different in memantine-treated rats compared with controls (A).
AID Hepa 0032 / 5p1e$$$622 03-13-97 14:48:47 hpta WBS: Hepatology NOTE. One-way ANOVA was used for differences between the experimental groups (which was statistically significant). The Scheffé procedure was used for individual group comparisons. Data are expressed in percentages as means { SEM. Memantine was administered to AI-PCS rats either i.p. 10 mg/kg body weight or i.v. 5 mg/kg body weight, and to LIS rats i.p. 10-20 mg/kg body weight.
Abbreviation: MEM, memantine. * P õ .05 versus normal rats. † P õ .05 versus control AI-PCS rats.
ous data of our experimental model of hyperammonemia-significantly. These results suggest that overstimulation of the NMDA-receptor activity is implicated in the pathogenesis induced encephalopathy in rats have suggested a role for elevated extracellular concentrations of glutamate and aspar-of hyperammonemia-induced encephalopathy and acute HE.
In addition, the improvement in EEG activity after NMDAtate in brain. 9 The increase in these excitatory amino acids may finally result in NMDA-receptor overactivity. This over-receptor blockade observed in both models suggests that NMDA-receptor activation is associated with changes in EEG stimulation of NMDA-receptor activity can induce cell swelling and/or neuronal degeneration. 19, 20 Cell swelling is caused activity. Indications of excitatory amino acid-induced alterations in EEG activity have been reported by Kuchiwaki et by an increased influx of sodium, chloride, and water, and neuronal degeneration is the result of an increased influx of al. 43 Despite high blood ammonia concentrations, brain water calcium. Because neuronal damages are not common in HE, we assume that astrocyte swelling is the most important neg-content and ICP were significantly decreased in AI-PCS rats after memantine administration. Assuming a possible link ative consequence of NMDA-receptor overstimulation in encephalopathy. The mechanism by which NMDA-receptor between neurological signs and cell swelling, this suggests that the improvement in clinical manifestations of encephaoverstimulation induces astrocyte swelling can be twofold: 1) indirectly by increasing the release of glutamate from neu-lopathy in AI-PCS rats may be at least partially caused by a reduction in cell swelling. However, memantine did not affect rons (shown by Bustos et al. 32 ), possibly resulting in astrocyte swelling, 33 or 2) directly by increasing the ion influx (Na / , brain water content or ICP in LIS rats, although clinical manifestations were improved. In this case, however, clinical Cl 0 ) into the astrocyte, if NMDA receptors are present on its membrane. 34 However, the presence of NMDA receptors on grading and EEG spectral analysis were measured directly after memantine administration, whereas ICP and brain waastrocytes has been suggested but not yet been proven. 35 If the NMDA-receptor-mediated cell swelling together with ter content were measured only at the end of the experiment, the time point at which the clinical manifestations of the the suggested cell swelling induced by increased concentrations of intracellular brain glutamine 8 is not restricted, life-treated LIS rats were similar to control LIS rats. Thus, it may be possible that NMDA-receptor blockade initially did threatening intracranial hypertension will finally develop.
To test the possible role of NMDA-receptor overactivity in result in a reduction of ICP and brain water content, which could result in an improvement of clinical manifestations of two different rat models of encephalopathy (i.e., hyperammonemia-induced encephalopathy and acute HE), the effect of encephalopathy. Ultimately, however, the blockade was insufficient with resultant increased ICP, increased brain wathe noncompetitive NMDA-receptor antagonist memantine was studied in AI-PCS rats and LIS rats. Memantine has ter content, and deterioration of clinical manifestations.
Other possible explanations for the absence in reduction of been used in neurological diseases like Parkinson's disease, dementia, and coma. [36] [37] [38] The therapeutic effect of memantine brain water content or ICP in LIS rats are: 1) differences in the type of brain edema (e.g., more cytotoxic in the LIS rats), is caused by selective blocking of the open ion-channel of the NMDA receptor 21,23,39,40 in a noncompetitive way, and its fast and 2) relatively more contribution of glutamine-induced osmotic swelling than NMDA-receptor overactivity. However, kinetics and voltage dependency are probably responsible for the lack of side effects at therapeutically used doses. It there-we cannot exclude the possibility that NMDA-receptor blockade would have reduced cell swelling in LIS rats if memanfore seemed worthwhile to study this lipophilic drug, with high affinity for the CNS, 41 in experimental encephalopathy. tine was administered earlier.
In that case, we assume that memantine was administered to these rats at the moment If NMDA-receptor overactivity does play a role in the pathogenesis of hyperammonemia-induced encephalopathy and that brain edema was no longer reversible.
Memantine treatment further resulted in a smaller or no acute HE, blockade of the NMDA receptor could be able to attenuate encephalopathy in both models.
increase in CSF concentrations of glutamate. This can be explained by the fact that stimulation of NMDA-receptor acIntraperitoneal and intravenous administration of memantine resulted in plasma concentrations of 334 { 32 ng/mL and tivity also promotes glutamate release, which is in agreement with the data of Bustos et al. 32 They reported that the addi-196 { 16 ng/mL at the end of the experiment, respectively. Because the CSF/plasma ratio of memantine has a value of tion of NMDA to the dialysate perfusion induces a release of glutamate and aspartate, measured by in vivo brain dialysis 0.5, 42 plasma concentrations of about 200 ng/mL will result in CSF concentrations of about 100 ng/mL (ie, approximately in rats. After administration of MK801, another noncompetitive NMDA-receptor antagonist, the increase of glutamate 0.5 mmol/L). The K i value of memantine for the NMDA receptor at normal resting membrane potentials is approximately and aspartate in brain dialysate was inhibited, indicating that NMDA-receptor activity enhances the release of gluta-1 mmol/L in rats, 21, 40 indicating that the doses of memantine used in our study could be expected to inhibit NMDA-receptor mate and aspartate.
The stimulation of glutamate release by NMDA-receptor activity by at least 50% to 80%.
In agreement with our hypothesis, both i.p. and i.v. admin-activity might be mediated by nitric oxide (NO), which is increased after NMDA-receptor activity by stimulation of NO istration of memantine in AI-PCS rats and i.p. administration in LIS rats attenuated the clinical manifestations of synthase. Montague et al. 44 showed that NMDA-receptormediated NO production and its diffusion into the extracelluencephalopathy (i.e., clinical grade and EEG activity)
